Safeguard Scientifics Deploys $1.33 Million into Sotera Wireless

  Safeguard Scientifics Deploys $1.33 Million into Sotera Wireless

   Sotera’s ViSi Mobile platform is a comprehensive, vital signs monitoring
 system that offers an effective, economical solution to enable hospitals to
             monitor their entire patient population in real time

Business Wire

WAYNE, Pa. -- February 6, 2013

Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that provides
growth capital and operational support to healthcare and technology companies,
deployed $1.33 million as part of a $14.8 million financing for Sotera
Wireless, Inc., a San Diego, Calif.-based medical device company that has
developed a new wireless patient monitoring platform called ViSi Mobile^®.
Sotera will use the proceeds from this financing to build out its sales
network and channel distribution partners.

In addition to Safeguard, participants in this round included new investor
Delphi Ventures and existing investors Sanderling Ventures, Qualcomm
Incorporated acting through its venture investment group Qualcomm Ventures,
EDBI, Intel Capital, Cerner Capital and West Health Investment Fund.

Sotera’s ViSi Mobile platform is a comprehensive vital signs monitoring system
that is designed to keep clinicians connected to their patients, whether in or
out of bed, or while in transport—“monitoring in motion.” Featuring
comfortable body-worn sensors that allow for freedom of movement, the system
enables highly accurate, continuous monitoring of all vital signs. The ViSi
Mobile system offers an effective, economical solution to enable hospitals to
monitor their entire patient population in real time. By some estimates,
around 60 percent of the approximately 1,000,000 U.S. hospital beds are not
continuously monitored. As a result, an avoidable death occurs every five
minutes at U.S. hospitals due solely to inadequate patient monitoring. Global
demand could significantly increase that opportunity.

“Sotera is led by an experienced management team of healthcare and business
professionals who have a track record of building successful businesses,” said
James A. Datin, Executive Vice President and Managing Director at Safeguard,
who joined Sotera’s board of directors. “We believe that Sotera’s ViSi Mobile
addresses a large market, with the opportunity to revolutionize the way
hospitals monitor patient vital signs. ViSi Mobile fills an unmet medical
need, has the potential to reduce healthcare spending, and can rapidly improve
patient management while achieving significant growth. Through this financing,
we can provide Sotera with the necessary resources to help increase ViSi
Mobile’s penetration into hospitals throughout the United States, and
encourage the development of other, complementary products that build upon
Sotera’s proprietary technology.”

“With $14.8 million in additional capital, we believe that we can accelerate
our commercialization and clinical development, and expand the availability of
ViSi Mobile to the more than 5,000 hospitals in the United States,” said Tom
Watlington, CEO of Sotera. “In addition, we are excited that Safeguard has
joined our board of directors. Safeguard is a highly-respected organization
with an impressive track record backing successful medical device
commercialization and marketing efforts, and we look forward to the value they
can bring to us through their domain expertise and partnership.”

Safeguard has a 7.7 percent primary ownership stake in Sotera, with the
potential to raise that ownership stake to 20 percent in certain scenarios.

About Safeguard Scientifics
Founded in 1953 and based in Wayne, Pa., Safeguard Scientifics, Inc. (NYSE:
SFE) provides growth capital and operational support to entrepreneurial and
innovative healthcare and technology companies in medtech, healthtech,
specialty pharmaceuticals, financial technology, digital media, and Enterprise
3.0. For more information, please visit our website at www.safeguard.com.

About Sotera Wireless
Sotera Wireless, Inc. is a San Diego, California based medical device company
dedicated to the development, marketing and sale of a new generation of
comprehensive vital signs monitoring. Sotera's mission is to improve patient
safety by empowering clinicians to detect early signs of deterioration in
virtually any care setting and enable early intervention and rapid response,
all without limiting the patient's freedom of movement. More information on
the company can be obtained at www.soterawireless.com or by sending an email
to info@soterawireless.com.

ViSi Mobile® is a registered trademark of Sotera Wireless, Inc.

Safeguard Press Resources
Blog: blog.safeguard.com
Twitter: @Safeguard
StockTwits: SFE
LinkedIn: Safeguard Scientifics
YouTube: SafeguardSFE
SlideShare: SafeguardScientifics

Forward-looking Statements
Except for the historical information and discussions contained herein,
statements contained in this release may constitute "forward-looking
statements" within the meaning of the Private Securities Litigation Reform Act
of 1995. The Company’s forward-looking statements are subject to risks and
uncertainties. The risks and uncertainties that could cause actual results to
differ materially, include, among others, managing rapidly changing
technologies, limited access to capital, competition, the ability to attract
and retain qualified employees, the ability to execute our strategy, the
uncertainty of the future performance of our partner companies, acquisitions
and dispositions of partner companies, the inability to manage growth,
compliance with government regulations and legal liabilities, additional
financing requirements, the effect of economic conditions in the business
sectors in which our partner companies operate, and other uncertainties
described in the Company's filings with the Securities and Exchange
Commission. Many of these factors are beyond our ability to predict or
control. In addition, as a result of these and other factors, our past
financial performance should not be relied on as an indication of future
performance. The Company does not assume any obligation to update any
forward-looking statements or other information contained in this news
release.

Contact:

Safeguard Scientifics
Media Contact:
Gregory FCA
Mike Lizun, 610-642-1435
Mike@GregoryFCA.com